MedPath

A Multi-Centered Randomized Double-Blinded Parallel Controlled Clinical Study on Efficacy of Warming the Kidney, Invigorating the Spleen, Activating Blood and Removing Edema Method in the Treatment of Chronic Heart Failure

Phase 1
Conditions
chronic heart failure
Registration Number
ITMCTR2000003867
Lead Sponsor
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Aged between 18 to 74years;
2. Those who meet the diagnostic criteria of Western medicine;and with II to III degree of the cardiac function stardand of New York Heart Association;
3. Those whose BNP content >= 150pg/ml(or Pro-BNP >= 600pg/ml);
4. Those whose the left ventricular ejection fraction (LVEF) was <= 40%;
5. Those who meet the syndrome differentiation of TCM;
6. Those who participate in this clinical trial voluntarily, understand and sign the informed consent.

Exclusion Criteria

1. Combine the serious primary disorders;
2. Combine serious infection;
3. Plan to accept Cardiac surgical procedures;
4. Critical patients who may cannot survive to the end of the trial;
5. Pregnant or lactating women;
6. Allergic Constitution, allergic to many kinds of medicine;
7. Patients with mental disorder and unwilling to cooperate;
8. Other conditions that are not suitable for participation in clinical trials.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
YHA grade;the total score of TCM syndrome;
Secondary Outcome Measures
NameTimeMethod
Plasma pro-BNP;LVEDD;EF;Kansas City Cardiomyopathy Questionnaire;LAD;6-minute walking test;Plasma BNP;Readmission rate;Minnesota heart failure quality of life score;
© Copyright 2025. All Rights Reserved by MedPath